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Abstract. 
 
The compartmentalization of plasma mem-
brane proteins has a key role in regulation of lympho-
cyte activation and development of immunity. We 
found that the proline-rich tyrosine kinase-2 (PYK-2/
RAFTK) colocalized with the microtubule-organizing 
center (MTOC) at the trailing edge of migrating natural 
killer (NK) cells. When polyclonal NK cells bound to 
K562 targets, PYK-2 translocated to the area of NK–
target cell interaction. The speciﬁcity of this process 
was assessed with NK cell clones bearing activatory or 
inhibitory forms of CD94/NKG2. The translocation of 
PYK-2, MTOC, and paxillin to the area of NK–target 
cell contact was regulated upon speciﬁc recognition of 
target cells through NK cell receptors, controlling tar-
get cell killing. Furthermore, parallel in vitro kinase as-
says showed that PYK-2 was activated in response to 
signals that speciﬁcally triggered its translocation and 
NK cell mediated cytotoxicity. The overexpression of 
both the wt and a dominant-negative mutant of PYK-2, 
but not ZAP-70 wt, prevented the speciﬁc translocation 
of the MTOC and paxillin, and blocked the cytotoxic 
response of NK cells. Our data indicate that subcellular 
compartmentalization of PYK-2 correlates with effec-
tive signal transduction. Furthermore, they also suggest 
an important role for PYK-2 on the assembly of the sig-
naling complexes that regulate the cytotoxic response.
Key words: CD94/NKG2 • cytotoxicity • microtu-
bule-organizing center • cytoskeletal proteins • HLA-E
 
Introduction
 
Cell compartmentalization and rearrangement of mem-
brane and cytosolic proteins seem to be required for lym-
phocyte activation and the development of immune re-
sponse (Dustin and Shaw 1999; Lanzavecchia et al., 1999;
Sánchez-Madrid and del Pozo, 1999; Serrador et al., 1999).
In addition, recent studies on the molecular reorganization
that occurs during the specific interaction of lymphocytes
with antigen-presenting cells revealed that different mole-
cules involved in T cell stimulation are compartmental-
ized, favoring the activation of these cells (Monks et al.,
1997, 1998; Wülfing and Davis, 1998; Xavier et al., 1998;
Viola et al., 1999; reviewed in Dustin and Shaw, 1999).
Therefore, there is growing evidence that molecular com-
partmentalization through protein–protein or protein–
lipid interactions may play an important role in regulating
cell signaling (Mochly-Rosen, 1995; Faux and Scott, 1996;
Pawson and Scott, 1997).
Natural killer (NK)
 
1
 
 cell cytotoxic activity is modulated
by positive and negative signals triggered by different
membrane receptors. NK cell receptors specifically inter-
act with molecular histocompatibility complex (MHC)
class I on target cells and function either as inhibitory or
activatory molecules. Thus, the human killer inhibitory re-
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Abbreviations used in this paper: 
 
EGFP, enhanced green fluorescent pro-
tein; FAK, Focal adhesion kinase; FN, fibronectin; HLA, human leuko-
cyte antigen; IL-2, interleukin-2; ITIM, immunoreceptor tyrosine-based
inhibitory motifs; MHC, molecular histocompatibility complex; MTOC,
microtubule-organizing center; NK, natural killer; PYK-2, proline-rich
tyrosine kinase 2; SHP, Src homology 2 domain containing protein ty-
rosine phosphatase. 
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ceptors from the immunoglobulin superfamily or some
members of another family of related Ig-like receptors
specifically interact with different human leukocyte anti-
gen (HLA) class I allotypes and suppress NK cell–medi-
ated cytotoxicity (Moretta and Moretta, 1997; Lanier,
1998; Yokoyama, 1998; Long, 1999; López-Botet and
Bellón, 1999). In contrast, another set of molecules homol-
ogous to the killer inhibitory receptors triggers NK cell ac-
tivity (Cosman et al., 1997; Samaridis and Colonna, 1997).
On the other hand, the CD94 C-type lectin NK cell recep-
tor covalently assembles with distinct members of the
NKG2 family, playing different functional roles. CD94/
NKG2A constitutes an inhibitory receptor coupled to
SHP tyrosine phosphatases through the immunoreceptor
tyrosine-based inhibitory motifs (ITIM) bearing NKG2A
subunit (Carretero et al., 1997, 1998; Leibson, 1997; Vivier
and Daëron, 1997; Le Drean et al., 1998). In contrast, the
association of CD94 with the NKG2C protein, highly ho-
mologous to NKG2A but lacking ITIMs, forms a trigger-
ing receptor linked to DAP-12 (Houchins et al., 1997; Can-
toni et al., 1998; Lanier et al., 1998a,b). Different signaling
events such as the rise of intracellular Ca
 
2
 
1
 
, activation
of PLC-
 
g
 
, and release of phosphoinositides, are involved
in the activation signaling pathway that ultimately trig–
gers the cytotoxic response, although the precise sequence
of these biochemical events has not been fully defined
(Daëron, 1997; Lanier, 1998).
Proline-rich tyrosine kinase 2 (PYK-2), also called
RAFTK (related adhesion focal tyrosine kinase), CAK-
 
b
 
(cell adhesion kinase 
 
b
 
), CADTK (cell adhesion–depen-
dent tyrosine kinase), or focal adhesion kinase-2 (FAK2),
is a member of the FAK non-receptor tyrosine kinase fam-
ily that is expressed by different cell types, including neu-
ral and hematopoietic cells (Avraham et al., 1995; Earp
et al., 1995; Lev et al., 1995; Sasaki et al., 1995; Herzog et al.,
1996). PYK-2 shares significant sequence homology with
FAK (60% identity in the central catalytic domain and
40% identity in both the COOH and NH
 
2
 
 termini) and
does not contain SH2 or SH3 domains, but bears several
binding sites for SH2/SH3-containing signaling proteins
(Avraham et al., 1995; Lev et al., 1995). PYK-2 can be acti-
vated by a variety of stimuli that induce a rise in intracellu-
lar calcium concentrations (Lev et al., 1995). In addition,
phorbol esters and agonists of G-protein–coupled recep-
tors as well as signals triggered through integrins, may lead
to tyrosine phosphorylation of PYK-2 (Lev et al., 1995;
Dikic et al., 1996; Li et al., 1996). It has been reported that
NK cells express PYK-2, but not FAK, and that 
 
b
 
1 and 
 
b
 
2
integrin outside-in signaling stimulates PYK-2 activation
(Gismondi et al., 1997; Rodríguez-Fernández et al., 1999).
Furthermore, it has been shown that PYK-2, together
with Src, functions as a link between heterotrimeric G-pro-
tein–coupled receptors and the mitogen-activated protein
(MAP) kinase signaling pathway (Dikic et al., 1996). Re-
cent studies indicate that PYK-2 may be also involved in
regulation of vesicular transport through its interaction
with a new GTPase activating protein designated Pap
(Andreev et al., 1999).
In this report, we found that changes in the subcellular
localization of the tyrosine kinase PYK-2 occur in an NK
cell receptor specifically regulated manner during the ef-
fector–target cell conjugate formation. The translocation
 
of PYK-2 from the trailing edge of NK cells to the area of
NK-target cell interaction correlated with its activation,
suggesting that the compartmentalization of PYK-2 signif-
icantly contributes to both the signal transduction in NK
cells and the microtubular rearrangements that occur dur-
ing the cytotoxic process. In addition, overexpression of
both a wt and a dominant-negative mutant of PYK-2, but
not ZAP-70 wt, blocked the NK cell–mediated cytotoxic
response, suggesting an additional role for PYK-2 in the
assembly of the signaling complexes that participate in the
cytotoxic response.
 
Materials and Methods
 
Cells
 
Interleukin-2 (IL-2)–cultured polyclonal NK cells were obtained essen-
tially as described (Aramburu et al., 1990). In brief, peripheral blood lym-
phocytes were cultured with irradiated (5 Gy) RPMI 8866 lymphoblastoid
cells for 6–9 d in RPMI 1640 supplemented with 10% FCS (complete me-
dium), followed by a negative selection step using an anti-CD3 mAb and
rabbit complement (Behring). The CD3
 
2
 
 cells (
 
,
 
5% CD3
 
1
 
) were cul-
tured with 50 IU/ml of rhIL-2 until use. We routinely obtained a cell pop-
ulation with 
 
.
 
95% of CD56
 
1
 
 and CD16
 
1
 
 cells and 
 
,
 
5% of CD3
 
1
 
,
CD19
 
1
 
, or CD14
 
1
 
 cells. NK cell clones were established as described
(Pérez-Villar et al., 1995). The inhibitory clones were selected by their
high ability to kill .221 target cells, that was inhibited by HLA-E in .221-
AEH cells. The selected activatory clones showed a low basal lysis of .221
target cells, thus allowing the detection of the lysis activation by HLA-E
on .221-AEH target cells. All cell cultures were systematically phenotyped
by flow cytometry analysis with a panel of NK receptor-specific mAbs, as
described (Pérez-Villar et al., 1997). The NKL cell line, kindly provided
by M. Robertson (Dana-Farber, Boston, MA; Robertson et al., 1996), was
maintained in RPMI 1640 medium supplemented with 10% (vol/vol) heat-
inactivated human AB serum, 2 mM glutamine, 1 mM sodium pyruvate,
and 100 U/ml IL-2.
The HLA class I–deficient EBV-transformed B lymphoblastoid cell
line 721.221 (.221) was grown in complete medium. The 721.221 cell line
transfected with the AEH chimeric construct (.221-AEH), in which the
HLA-E leader sequence is replaced by that of HLA-A2 was kindly pro-
vided by Dr. Geraghty (Lee et al., 1998).
 
Antibodies and Reagents
 
The anti-CD56 mAb (C218) was kindly provided by Dr. A. Moretta (Isti-
tuto Nazionale per la Ricerca sul Cancro e Centro Biotecnologie Avan-
zate, University of Genova, Genova, Italy). The anti-CD94 (HP-3B1) and
the anti–HLA-class I (HP-1F7) mAbs have been described (Pérez-Villar
et al., 1995). PYK-2 affinity-purified anti-peptide polyclonal antibodies
C-19 and N-19, as well as
 
 
 
the C-19 antibody cognate blocking peptide
were from Santa Cruz Biotechnology, Inc. The anti–
 
g
 
-tubulin
 
 
 
and anti-
talin were purchased from Sigma-Aldrich. The anti-paxillin mAb was
from Transduction Laboratories, and the anti-Tyr(P) 4G10 was from
Santa Cruz. The anti-moesin 38/87 was kindly provided by Dr. R.
Schwartz-Albiez (German Cancer Research Center, Heidelberg, Ger-
many) and has been described (Lankes et al., 1988). The anti-p37 15B6
mAb was kindly provided by Dr. R. Blasco (Instituto Nacional de Investi-
gaciones Agrarias, Madrid). The anti-ZAP-70 701 polyclonal antibody
was generously provided by Dr. B. Alarcón (Centro de Biología Molecu-
lar “Severo Ochoa”, Madrid). 
 
g
 
-[
 
32
 
P]ATP (4,000 Ci/mmol) was from ICN,
and protein A–agarose and protein G–agarose were from Boehringer
Mannheim. Enhanced chemiluminescence (ECL) reagents were from
Amersham, and all other reagents used were of the purest grade available.
 
Immunofluorescence Analysis
 
NK cells (5 
 
3 
 
10
 
5
 
) were added to coverslips coated with 30 
 
m
 
g/ml fibronec-
tin (FN) in flat-bottomed, 24-well plates (Costar Corp.) in a final volume
of 500 
 
m
 
l complete medium and allowed to settle for 30 min at 37
 
8
 
C in a
5% CO
 
2
 
 atmosphere. Then, cells were either fixed and permeabilized with
0.5% Triton, 2% formaldehyde, PBS or fixed in 2% formaldehyde, and
then permeabilized in 0.1% saponin, 1% BSA, 0.005% NaN
 
3
 
, PBS, and 
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stained with appropriate antibodies as previously described (Nieto et al.,
1998).
For studies of cell conjugates, 1 
 
3
 
 10
 
5
 
 target cells were added to cover-
slips coated with 30 
 
m
 
g/ml FN in flat-bottomed, 24-well plates (Costar
Corp.) in a final volume of 500 
 
m
 
l complete medium and allowed to settle
30 min at 37
 
8
 
C in a 5% CO
 
2
 
 atmosphere. Nonadherent cells were aspi-
rated and 1 
 
3
 
 10
 
5
 
 NK cells in 500 
 
m
 
l complete medium were then added
and incubated for 1 h at 37
 
8
 
C in a 5% CO
 
2
 
 atmosphere. Cells were then
fixed and permeabilized as previously indicated, stained with the indicated
antibodies, and analyzed using a Nikon Labophot-2 photomicroscope with
a 100
 
3
 
 oil immersion objective. Confocal microscopy was performed as
described (Rodríguez-Fernández et al., 1999) using a MRC-1024 Confocal
Laser Scanning System (Bio-Rad Labs.).
 
Cytotoxic Assays
 
Microcytotoxicity chromium (
 
51
 
Cr) release assays were performed as de-
scribed (Pérez-Villar et al., 1997), using 721.221 and .221-AEH target
cells. The antagonistic effect of anti-CD94 mAb (for effectors) or anti-
HLA mAb (for targets) was tested by preincubating cells for 10 min be-
fore performing the cytotoxicity assay. The percent of specific lysis was
calculated (Aramburu et al., 1990) and only those experiments with a
spontaneous release under 20% of the maximum 
 
51
 
Cr release were consid-
ered.
 
Cell Lysates and Immunoprecipitation Assays
 
The NKL cell line and the target cell lines (.221 and .221-AEH) were
washed twice with RPMI 1640. Experiments were initiated by mixing 10
 
7
 
effector cells and 2 
 
3
 
 10
 
6
 
 of each target cells (.221 or .221-AEH) in a final
volume of 200 
 
m
 
l. When indicated, target cells were previously fixed in 1%
paraformaldehyde and washed extensively before incubating with NK
cells. Cells were spun, incubated at 37
 
8
 
C for the indicated times, and lysed
in 1 ml of ice-cold lysis buffer (10 mM Tris-HCl, pH 7.65, 5 mM EDTA,
150 mM NaCl, 30 mM sodium pyrophosphate, 50 mM NaF, 2 mM sodium
orthovanadate, 1% Triton X-100, 50 
 
m
 
g/ml aprotinin, 50 
 
m
 
g/ml leupeptin,
5 
 
m
 
g/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride). Cell lysates
were clarified by centrifugation at 14,000 rpm for 10 min, and superna-
tants were immunoprecipitated at 4
 
8
 
C overnight with protein G–agarose
coupled to goat polyclonal anti-PYK-2 (C-19) antibodies. Immunoprecipi-
tates were washed three times with lysis buffer, and either used for in vitro
kinase assays or Western blot (see below).
 
In Vitro Kinase Assay
 
This assay was performed as described (Rodríguez-Fernández and Rozen-
gurt, 1998). Briefly, immunoprecipitates were washed three times in lysis
buffer and twice with kinase buffer (20 mM Hepes, 3 mM MnCl
 
2
 
, pH
7.35), pellets dissolved in 40 
 
m
 
l of kinase buffer, and reactions initiated by
adding 10 
 
m
 
Ci of 
 
g
 
-[
 
32
 
P]ATP. The reactions were carried out at 30
 
8
 
C for
15 min, and stopped by transferring to ice and adding 10 mM EDTA. Pel-
lets were then washed in lysis buffer containing 10 mM EDTA, extracted
for 5 min at 95
 
8
 
C in 2
 
3
 
 SDS-PAGE sample buffer and analyzed by SDS-
PAGE. Autoradiograms were processed using an AGFA Studio ScanIIsi
scanner and bands were quantified using the Biorad Multi-Analyst Soft-
ware.
 
Western Blot
 
After SDS-PAGE, immunoprecipitated proteins were transferred to Im-
mobilon membranes using a Bio-Rad SD Transblot. Membranes were
then blocked with 3% nonfat dried milk in PBS, pH 7.2, and incubated for
2 h RT with anti–PYK-2 (C-19 or N-19) polyclonal antibodies at a 1:500
dilution, anti PTyr 4G10 mAb at 1 
 
m
 
g/ml, and anti-p37 15B6 polyclonal
antibody at a 1:50 dilution in PBS containing 3% nonfat dried milk.
Bound antibodies were detected with horseradish peroxidase conjugate
secondary antibodies, followed by visualization by ECL reagents.
 
Recombinant Vaccinia Viruses and Vaccinia Virus 
Infection of NKL Cell Line and NK Clones
 
To generate recombinant vaccinia viruses encoding the wt and the kinase
dead form of PYK-2, the full-length PYK-2 and PYK-2 K457A (PYK-2
K-M) cDNAs (Li et al., 1996) were subcloned as a HindIII-XbaI fragment
into the pRB21 vector (kindly provided by Dr. J.A. Melero, Instituto de
Biología Fundamental, Instituto de Salud Carlos III, Madrid). The full-
 
length ZAP-70 wt cDNA in EcoRI site of pSV.10.1 (kindly provided by
Dr. B. Alarcon) was subcloned in EcoRI site of pRB21. Then, the rele-
gated pRB21 vector and the constructs containing ZAP-70 wt, PYK-2 wt
and PYK-2 (K-M) in the correct orientation were inserted into the defec-
tive vRB12 strain of vaccinia virus (Blasco and Moss, 1995) by homolo-
gous recombination. Selection of recombinants was carried out by plaque
formation as described (Blasco and Moss, 1995). Viruses were then
cloned, purified, and standard viral plaque assays on CV1 cells were used
to determine the titer of each of the recombinants. To generate PYK-
2-EGFP fusion proteins, PYK-2 cDNAs were subcloned as a HindIII-
XbaI fragment into the pEGFPC3 vector (CLONTECH Laboratories,
Inc.), and then the NheI-XbaI fragment subcloned in the pRB21 vector.
ZAP-70-EGFP (kindly provided by Dr. B. Alarcón) was subcloned as an
EcoRI-XbaI fragment into the pRB21 vector. As described before, vi-
ruses encoding EGFP, EGFP-ZAP-70 wt, EGFP-PYK2 wt, and EGFP-
PYK-2 (K-M) fusion proteins were generated.
NKL cell line and NK clones were infected by recombinant vaccinia vi-
ruses essentially as described previously (Wagtmann et al., 1995). In brief,
NKL cells and NK clones were washed three times with infection medium
(Iscove’s, 0.5% BSA, 1
 
3
 
 nonessential amino acids, 2 mM 
 
L
 
-glutamine) at
room temperature and resuspended at 10
 
6
 
 cells/ml in infection medium.
Cell suspensions were given either no virus or recombinant vaccinia virus
(control pRB21, ZAP-70 wt, PYK-2 wt, PYK-2 (K-M), or the EGFP fu-
sion proteins) at 20 pfu/cell and incubated 2 h at 37
 
8
 
C with occasional stir-
ring. After one wash in complete RPMI, the vaccinia-infected or unin-
fected control cells were simultaneously plated for standard 
 
51
 
Cr-release
killing assays, for Western blot, and for immunofluorescence analysis as
described. The level of infection was monitored by measuring the expres-
sion of the viral envelope p37 protein in the infected cells by Western blot.
 
Results
 
PYK-2 Colocalizes with the MTOC in Migrating
NK Cells
 
IL-2–activated NK lymphocytes show a high degree of cell
polarization, in accordance with their high locomotive ca-
pability (Somersalo, 1996–1997; Nieto et al., 1998). Immu-
nofluorescence studies were performed to determine the
cytoplasmic distribution of PYK-2 in IL-2–activated NK
cells adhered and migrating onto FN. Confocal micros-
copy analysis revealed that PYK-2 is highly concentrated
in a specific location in the cytoplasm of both rounded and
polarized NK cells adhered to FN (Fig. 1 a, A and B). In
polarized NK cells, the majority of PYK-2 was concen-
trated at the uropod, the cytoplasmic projection developed
at the rear of polarized cells. Double staining of cells for
PYK-2 and moesin, a member of the ezrin-radixin-moesin
family of proteins that connects the cell membrane to the
actin-cytoskeletal network and that marks the cytoplasmic
membrane of the uropod (Serrador et al., 1997), con-
firmed that PYK-2 localizes at this protrusion of polarized
NK cells (Fig. 1 a, C). A small fraction of PYK-2 was also
observed at the advancing front of some NK cells (Fig. 1 a,
A) colocalizing with talin, a cytoskeletal protein involved
in the formation of integrin-mediated cell adhesion con-
tacts with substratum (Fig. 1 a, D). As the uropod is the
site of microtubule retraction (Ratner et al., 1997; Serra-
dor et al., 1997), we performed immunofluorescence stud-
ies to determine the localization of MTOC in migrating,
polarized NK cells. Confocal sections of cells double-
stained for 
 
g
 
-tubulin, a microtubule protein that is a highly
conserved component of the MTOC (Stearns et al., 1991;
Zheng et al., 1991), and for PYK-2, demonstrated that this
tyrosine kinase colocalizes with 
 
g
 
-tubulin, and thus with
the MTOC, at the uropod of polarized NK cells adhered to
FN (Fig. 1 b). 
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Figure 1. PYK-2 is localized at the uropod projection of NK cells adhered to fibronectin. (a) Confocal section of PYK-2 immune stain-
ing of NK cells migrating on FN (A). The same section under brightfield illumination is shown in B. Epifluorescence images of NK cells
double-stained for PYK-2 (green) and moesin (red, C), and PYK-2 (green) and talin (red, D). Control cells stained with goat serum or
secondary antibody alone did not show any specific staining, and preincubation of the anti-PYK-2 antiserum with its specific blocking
peptide prevented staining of NK cells (not shown). (b, A) Confocal serial sections of polarized NK cells adhered to FN and double-
stained for g-tubulin (red, upper panels, g-TUB) and PYK-2 (green, lower panels, PYK-2). Sections were taken every 0.8 mm from
the substratum (0) in the z-axis. b, B shows a merged image of double-labeled cells demonstrating the colocalization of g-tubulin and
PYK-2 at the uropod of NK cells. 
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PYK-2 Is Translocated in NK Cells to the Area of
Cell-to-Cell Contact during Specific Recognition of 
Target Cells
 
To assess whether PYK-2 is translocated during the killing
process, we investigated the cellular localization of PYK-2
in NK–target cell conjugates. In a first set of experiments,
K562 cells were used as targets since these cells do not ex-
press classical MHC class I molecules and are efficiently
killed by IL-2–activated polyclonal NK cells. As it has
been described (Nieto et al., 1998), asymmetrical binding
of NK cells to target cells through the NK cell leading edge
was observed, with the uropod projecting away from the
area of cell–cell contact (Fig. 2). When NK–K562 cell con-
jugates were stained with anti–PYK-2 polyclonal antibod-
ies, it was found that this kinase concentrated in a specific
domain of the effector cells that faces the site of adhesion
with the target cell (Fig. 2). In addition, in some effector
cells, PYK-2 localized to cell-to-cell contact areas. In con-
trast, no staining for PYK-2 was detected at the cell uro-
pod, developed at the opposite site of the contacting re-
gion. Therefore, PYK-2 is translocated from the rear of
the cell to the area of cell contact during effector–target
cell conjugate formation.
The triggering receptors for lysis of K562 cells have not
been defined yet. To ascertain whether the translocation
of PYK-2 in NK cells was related to the recognition of tar-
get cells through specific receptors, the positioning of
PYK-2 was determined during the interaction of distinct
NK cell clones with target cells that show a different sensi-
tivity to be killed. To this end, we have used two different
types of NK cell clones that express CD94/NKG2C or
CD94/NKG2A heterodimers that interact with HLA-E.
Fig. 3 shows the cytotoxic activity of NKG2A- and
NKG2C-bearing NK cell clones against target cells ex-
pressing (.221-AEH) or not (.221) HLA-E. NKG2A
 
1
 
 cell
clones showed an efficient cytotoxicity against .221 cells,
but not to .221-AEH. The protection conferred by HLA-E
was reversed by blocking mAbs against both CD94 and
MHC I molecules, demonstrating that the inhibitory signal
of cytotoxicity was induced through the specific interac-
tion of these molecules. In contrast, the lytic ability of the
NK clones that express the CD94/NKG2C is enhanced by
.221-AEH HLA-E–bearing cells (Borrego et al., 1998;
Braud et al., 1998; Lee et al., 1998; Llano et al., 1998).
Hence, we selected some activatory clones whose basal ly-
sis against .221 was low, thus allowing the detection of the
enhancing effect by HLA-E (Fig. 3). In this case, mAbs
against CD94 and MHC I molecules blocked the activa-
tion signal induced by HLA-E (Fig. 3).
NKG2A
 
1
 
 and NKG2C
 
1
 
 cell clones were allowed to in-
teract with .221 or .221-AEH target cells and then PYK-2
was stained in effector–target cell conjugates, and ana-
lyzed by confocal microscopy. In conjugates of inhibitory
NKG2A
 
1
 
 cell clones with HLA-E–bearing target cells
(.221-AEH), PYK-2 was clearly located at the cell uropod.
In contrast, PYK-2 was found facing the area of cell–cell
interaction in NK cells when .221 target cells did not ex-
press HLA-E (Fig. 4 a, left panels, and Table I). The cor-
relation between the triggering of cytotoxic activity and
Figure 2. PYK-2 is localized at the intercellular
contact area of NK–K562 target cell conjugates.
Effector–target cell conjugates of polyclonal NK
cells (E) and K562 target cells (T) were stained
for PYK-2. Cells were photographed under epi-
fluorescence conditions (left) or phase contrast
illumination (right).
Figure 3. Cytotoxic response of NKG2A1 and NKG2C1 NK cell
clones against .221 or .221-AEH cells. NK cell clones whose kill-
ing activity is inhibited (NKG2A1) or activated (NKG2C1) by
HLA-E were tested in a 51Cr-release assay against .221 (HLA-
E2) or .221-AEH (HLA-E1) target cells. This figure also shows
the effect of anti-CD94 HP3B1, anti–MHC class I 1F7, and anti-
CD56 C218 (control) mAbs, on the cytotoxic response. Repre-
sentative data from three independent experiments are shown as
arithmetic mean 6 SE. 
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Figure 4. PYK-2 and the MTOC are translocated to the area of cell–cell contact of NK cells with target cells during specific recognition
and cytotoxicity. (a) Confocal sections showing PYK-2 localization on NK cell clones (E) which are inhibited (CD94/NKG2A), or acti-
vated (CD94/NKG2C) by HLA-E, and that were interacting with HLA-E2 (.221) or HLA-E1 (AEH) target cells (T). Cell–cell conju-
gates were stained for PYK-2 (green) and CD94 (red) and analyzed using confocal microscopy. Confocal sections under brightfield illu-
mination are shown for each conjugate. Arrowheads show the localization of PYK-2 on effector cells. (b) MTOC localization on NK
cell clones that are inhibited (CD94/NKG2A), or activated (CD94/NKG2C) by HLA-E, and that were interacting with HLA-E2 (.221)
or HLA-E1 (AEH) target cells. Cell conjugates stained for g-tubulin were photographed under epifluorescence (red) and brightfield
conditions using a Nomarski 603 objective. T and E indicate target and effector cells, respectively, while arrowheads point to the
MTOC on effector cells. 
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translocation of PYK-2 was further confirmed in recip-
rocal experiments using activatory NKG2C-expressing
clones. In this case, PYK-2 was mainly localized at the NK
cell uropod in cell conjugates formed with .221 target cells,
whereas it was translocated to the cell-to-cell contact area
when cytotoxicity was triggered by recognition of HLA-E
on .221-AEH cells (Fig. 4 a, right panels, and Table I).
 
Changes in the Distribution of Cytoskeletal 
Components during NK Cell Receptor–mediated 
Effector–Target Cell Interaction
 
It has been described that the MTOC of cytotoxic T lym-
phocytes is translocated to face the area of cell adhesion
with the target cell during the cytotoxicity process (Kupfer
and Singer, 1989). Therefore, it was of interest to analyze
the effect of NK cell–specific cytotoxic triggering in the
cellular positioning of some cytoskeletal components. We
then characterized the MTOC translocation triggered by
CD94/NKG2-specific recognition. In accordance with their
cytotoxic responses, the translocation of the MTOC ob-
served when NKG2A
 
1
 
 clones interacted with .221 targets
was inhibited when killing was prevented by HLA-E in
.221-AEH cells (Fig. 4 b, left panels, and Table I). Con-
versely, an efficient translocation of the MTOC was ob-
served on CD94/NKG2C NK cell clones interacting with
.221-AEH target cells. The frequency of MTOC transloca-
tion was very low when these clones interacted with .221
target cells (Fig. 4 b, right panels, and Table I). Thus, the
triggering of cytotoxic activity in these clones correlated
with the translocation of MTOC to the area of interaction
with sensitive target cells.
It has been recently reported that PYK-2 is constitu-
tively associated to paxillin in NK cells (Gismondi et al.,
1997). Accordingly, we found that paxillin colocalized with
PYK-2 at the site of MTOC, and that both paxillin and
PYK-2 were translocated to the cell–cell contact area
when NK cell clones were bound to sensitive, but not to
resistant target cells (Fig. 5). In contrast, no changes in the
subcellular localization of other cytoskeletal components
such as moesin, localized at the NK cell uropod, or talin,
which participates in integrin-mediated cell adhesion and
localizes at cell-to-cell boundaries areas, were observed
upon triggering of killing (Fig. 5). These results demon-
strate that PYK-2 and paxillin are specifically translo-
cated, correlating with microtubular rearrangements, to
the area of NK cell–target cell interaction in response to
NK cell receptor–mediated specific signals that modulate
cytotoxicity.
 
PYK-2 Activation during Cytotoxic Activity of NK Cells
 
The selective translocation of PYK-2 during target cell
killing suggests that this tyrosine kinase is activated as a
consequence of the signals involved in the triggering of cy-
totoxicity. To assess this possibility, we analyzed the acti-
vation of PYK-2 during killing by an in vitro kinase assay
using as effector the CD94/NKG2A expressing NKL cell
line. The cytotoxic response and the translocation of the
MTOC and PYK-2 in this cell line are similar to the CD94/
NKG2A clones described above, and they are also inhib-
ited upon recognition of HLA-E (data not shown). To an-
alyze the kinase activity of PYK-2 during cytotoxicity, this
kinase was immunoprecipitated from cell lysates of mix-
tures of NKL cells with either .221 wild-type cells or cells
expressing HLA-E (.221-AEH). Immunoprecipitates were
incubated with 
 
g
 
-[
 
32
 
P]ATP and analyzed by SDS-PAGE.
The results obtained revealed a statistically significant dif-
ference between the activation state of PYK-2 in the two
distinct effector–target cell conjugates (Fig. 6, a and b).
Correlating with the triggering of cytotoxic activity (65.7 
 
6
 
5.6% specific lysis), PYK-2 was clearly activated when
NKL cells interacted with wild-type–sensitive .221 cells. In
contrast, a significant lower change in the activation state
of PYK-2 was observed when NKL cells interacted with
.221-AEH cells, which trigger an inhibitory signal resulting
in a lower cytotoxic activity (27.5 
 
6 
 
3.8% specific lysis).
Immunoblotting with anti–PYK-2 C-19 antibody immuno-
precipitates carried out in parallel verified that similar
amounts of PYK-2 were recovered in each case (Fig. 6, a
and b). Kinase activity was not detected when the PYK-2
antibody was preincubated with the immunizing peptide
before the addition to the lysates or when the lysates were
immunoprecipitated with a nonspecific goat serum (results
not shown). Kinetics studies showed that the increase in
the kinase activity of PYK-2 during cytotoxicity reached a
maximum from 25 to 45 min (Fig. 6 c). The possible contri-
bution of PYK-2 protein from target cells was ruled out
when the same experiments performed with fixed target
cells rendered similar results (data not shown). Fixation of
target cells did not affect their capability to induce translo-
cation of PYK-2 or MTOC on NK cells (data not shown).
These results indicate that PYK-2 is activated in response
to NK cell receptor-driven specific signals that lead to NK
cell–mediated cytotoxicity.
 
Overexpression of PYK-2 in NK Cells Inhibits 
Cytotoxicity and Translocation of MTOC and Paxillin
 
To further assess the role of PYK-2 in the cytotoxic re-
sponse, we used a vaccinia virus system to overexpress the
wt and a kinase dead mutant of PYK-2 (PYK-2 KM) in the
NKL cell line. Immunoblotting analyses with anti–PYK-2
confirmed the overexpression of the wt and the kinase
dead mutant of PYK-2 (Fig. 7 a). As expected, overexpres-
sion of PYK-2 wt resulted in a substantial increase in the
PYK-2 autokinase activity in immunoprecipitates from ly-
sates of NKL-infected cells. In contrast, PYK-2 immuno-
precipitates from cells infected with the kinase dead mu-
tant PYK2 K-M did not show any kinase activity and,
 
Table I. Frequency of Translocation of PYK-2 and MTOC in 
NK Cells Interacting with Target Cells
 
PYK-2 MTOC
CD94/NKG2A
(INH)
CD94/NKG2C
(ACT)
CD94/NKG2A
(INH)
CD94/NKG2C
(ACT)
 
.221 78.7 
 
6 
 
13.5 32.6 
 
6 
 
8.9 75.5 
 
6 
 
12.8 30.1 
 
6 
 
7.5
AEH 23.1 
 
6 
 
8.3 81.2 
 
6 
 
15.4 19.2 
 
6 
 
7.4 82.7 
 
6 
 
17.9
 
NK cells bearing the activatory (CD94/NKG2C), or inhibitory (CD94/
NKG2A) receptors for HLA-E were allowed to interact with .221 (HLA-E
 
2
 
)
or .221-AEH (HLA-E
 
1
 
) target cells on FN-coated plates. After 1 h, cell conju-
gates were fixed, and stained for PYK-2 or 
 
g
 
-tubulin. Translocation of PYK-2
or MTOC was measured in more than 100 conjugates in three independent ex-
periments. Results correspond to the arithmetic mean 
 
6 
 
SD. 
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instead, it caused a significant inhibition of the basal ki-
nase activity of endogenous PYK-2 (Fig. 7 a), as previ-
ously described (Sieg et al., 1998; Kumar et al., 1999). No
significant effect on the kinase activity of PYK-2 was ob-
served when cells were infected with the control VV
pRB21 at the same pfu/cell. Equivalence of the level of in-
fection between the vaccinia viruses containing different
constructs was assessed by analysis of the expression of the
viral p37 protein (Fig. 7 a).
To assess the specificity of the effect of PYK-2 overex-
pression on NK cell function, we generated ZAP-70 wt vi-
ruses overexpressing an equivalent level of this tyrosine
kinase, compared to the overexpression of PYK-2 (Fig. 7
b). The ZAP-70 kinase has been previously described not
to affect cytotoxicity (Brumbaugh et al., 1997). We then
analyzed the cytotoxic activity of the NKL infected with
the different vaccinia viruses against the .221-sensitive tar-
get. Interestingly, the killing was inhibited by the overex-
pression of both the wt and the kinase dead PYK-2, as
compared to the slight effect of the infection with control
pRB21 vaccinia virus and the tyrosine-kinase ZAP-70
(Fig. 7 c). In addition, the overexpression of another ki-
nase, the serine-threonine kinase PAK-1, did not affect cy-
totoxicity, further confirming the specificity of the effect of
PYK-2 on NK cell–mediated killing (data not shown).
To explore the mechanism by which overexpression
of PYK-2 inhibits the cytotoxic activity, we studied the
subcellular localization of the different forms of PYK-
2-EGFP fusion proteins and its influence on MTOC trans-
location. Vaccinia viruses were used to overexpress PYK-2
wt-EGFP, PYK-2 (K-M)-EGFP, ZAP-70-EGFP, and
EGFP fusion proteins. Inhibitory clones (CD94/NKG2A)
were infected and allowed to interact with .221 target cells,
subcellular localization of MTOC, and paxillin studied by
immunofluorescence analysis (Fig. 8 a). PYK-2 wt-EGFP
and (K-M)-EGFP showed a broad distribution throughout
Figure 5. Subcellular local-
ization of different cytoskele-
tal proteins in NK/target cell
conjugates. Cytoplasmic lo-
calization of PYK-2 (green)
and the cytoskeletal proteins
moesin, talin, and paxillin
(red) in cell conjugates
formed by NK cell clones
(E) which are inhibited by
HLA-E1 (INH-AEH) but
not by HLA-E2 (INH-.221)
target cells (T). Arrowheads
indicate staining of the pro-
tein indicated at each panel.Sancho et al. PYK-2/RAFTK Regulates NK Cell Cytotoxicity 1257
the cell cytoplasm, with a higher concentration colocaliz-
ing with the MTOC and paxillin, whereas EGFP and
ZAP-70-EGFP were found uniformly distributed in the
cell cytoplasm (Fig. 8 a, and not shown). As expected, effi-
cient translocation of the MTOC to the area of contact
with target cells was observed on cells overexpressing
EGFP or ZAP-70-EGFP, and only a slight reduction on
the frequency of MTOC translocation was observed as
compared to uninfected cells (Fig. 8, a and b). Interest-
ingly, overexpression of both the fusion proteins PYK-2
wt-EGFP and PYK-2 (K-M)-EGFP inhibited the translo-
cation of MTOC and paxillin in response to the sensitive
.221 target cell (Fig. 8, a and b). Given the well-known in-
teractions of PYK-2 with several regulatory molecules
Figure 6. PYK-2 activation during the cytotoxic response. (a)
NKL cells bearing the inhibitory CD94/NKG2A receptor were
allowed to interact with HLA-E2 (.221) or HLA-E1 (AEH) tar-
get cells for 25 min and then, half of the lysate was used to immu-
noprecipitate PYK-2 with the C-19 antibody and to perform an in
vitro kinase reaction, and the other half to quantify the levels of
PYK-2 by Western blot. Arrows indicate bands corresponding to
PYK-2. (b) Statistical analysis of PYK-2 activation. The results of
in vitro kinase assays performed as indicated in panel a are ex-
pressed as arithmetic mean 6 SE of intensity expressed in pixel
density units (P.D.U.) and represent three independent experi-
ments. *, P , 0.05 compared to the other times and treatments
(Student’s t test). (c) Kinetics of the phosphorylating activity of
PYK-2. NKL cells bearing the inhibitory CD94/NKG2A receptor
were allowed to form conjugates with .221 or .221-AEH cells for
different periods of time. Then, an in vitro kinase reaction was
performed in cell lysates, as described in Materials and Methods.
A representative experiment out of three is shown in the upper
panel, whereas the mean intensity in P.D.U. of this experiment is
depicted in the lower panel.
Figure 7. Overexpression of PYK-2 wt and PYK-2 (K-M) inhib-
its NK cells cytotoxic response. (a) Lysates from NKL cells unin-
fected (NO VV), infected with control vaccinia virus (pRB), in-
fected with PYK-2 wt (PYK WT), or infected with PYK-2 (K-M)
(PYK KM) were immunoprecipitated (IP) with C-19 anti–PYK-2
polyclonal antibody, analyzed by Western blotting (WB) with
anti–PYK-2 polyclonal antibody, and parallel samples were as-
sayed for in vitro autokinase activity. Whole cell lysates of these
samples were analyzed by Western blotting with anti-p37 15B6
mAb. (b) Lysates from NKL cells uninfected (NO VV), infected
with control vaccinia virus (pRB), infected with ZAP-70 (ZAP-
70), infected with PYK-2 wt (PYK WT), or infected with PYK-2
(K-M) (PYK KM) were analyzed by Western blotting (WB) with
C-19 anti–PYK-2 polyclonal antibody, 701 anti–ZAP-70 poly-
clonal antibody, and 15B6 anti-p37 mAb. (c) NKL cells unin-
fected (NO VV), infected with control VV (VVpRB21), infected
with ZAP-70 (VV ZAP-70), infected with PYK-2 wt (VV PYK-2
wt), or infected with PYK-2 (K-M) (VV PYK-2 KM) were tested
in a 51Cr-release assay against their sensitive target .221. Repre-
sentative data from three independent experiments are shown as
the mean percent specific lysis versus E/T ratio. The inhibition of
cytotoxic response by overexpression of PYK-2 is significant (P ,
0.05, Student’s t test) for all E/T ratios tested.The Journal of Cell Biology, Volume 149, 2000 1258
(Gismondi et al., 1997; Schlaepfer et al., 1999), these re-
sults suggest that PYK-2 has an important additional role
as a scaffolding protein, whose overexpression deregulates
the balance of signaling complexes that control the killing
response, probably by interfering with the microtubular
rearrangements involved in the translocation and orienta-
tion of the secretory apparatus.
Discussion
We report herein the changes in the subcellular localiza-
tion of the tyrosine kinase PYK-2 in NK cells and its acti-
vation during the effector–target cell conjugate formation
and the triggering of cytotoxic activity. In addition, we
provide evidence on the role of PYK-2 in the regulation of
cytoskeletal rearrangements, required for NK cell–mediated
killing activity. It is now becoming evident that in addition
to other regulatory elements such as phosphorylation or
aggregation of molecules, protein compartmentalization
provides an additional modulatory mechanism in the cell
(Mochly-Rosen, 1995; Faux and Scott, 1996; Pawson and
Scott, 1997). Subcellular positioning of signaling molecules
can be accomplished by their association with cytoskeletal
scaffolds or, as it has been recently demonstrated, by their
preferential localization into specific cell membrane do-
mains (Dustin and Shaw, 1999). The selective confining of
proteins into specific cell domains has been shown to be of
particular importance during the immune response (re-
viewed in Dustin and Shaw, 1999; Lanzavecchia et al.,
1999; Penninger and Crabtree, 1999; Serrador et al., 1999).
During the T cell response, the concentration of several
proteins, including the T cell receptor molecules, into dis-
tinct segregated domains, is necessary to accomplish T cell
activation. Interestingly, the protein kinase C-u and Src-
Figure 8. Overexpression of PYK-2 wt-EGFP and PYK-2 (K-M)-EGFP prevents the translocation
of MTOC and paxillin during specific target recognition. (a) NK inhibitory clones were infected
with control VV-pRB21-EGFP (EGFP) (upper left panels), ZAP-70-EGFP (upper right panels),
PYK-2 wt-EGFP (lower left panels), and PYK-2 (K-M)-EGFP (lower right panels). NK cell conju-
gates with the sensitive .221 target were studied by immunofluorescence. EGFP green fluores-
cence shows the infected NK cells (left panels). The red fluorescence corresponds to g-tubulin
(MTOC) staining (right panels). T and E indicate target and effector cells, respectively, while ar-
rowheads point to the MTOC on effector cells. (b) Quantification of the translocation of MTOC
and paxillin in conjugates formed by a green (infected) NK cell from inhibitory clones and its sen-
sitive target .221. Translocation of MTOC or paxillin was measured in .100 conjugates in three in-
dependent experiments. Results correspond to the arithmetic mean 6 SD.Sancho et al. PYK-2/RAFTK Regulates NK Cell Cytotoxicity 1259
kinase family members Lck and Fyn colocalize with the T
cell receptor complex at the area of cell–cell contact dur-
ing antigen presentation (Monks et al., 1997, 1998). Alto-
gether these observations suggest that protein compart-
mentalization, via recruitment and inclusion of activating
signaling molecules and exclusion of potential negative
regulators, may provide a unique restricted subcellular mi-
croenvironment that promotes optimal signal transduc-
tion. By this way, the cytoskeleton can directly regulate,
both temporally and spatially, the molecular dynamics of
signaling pathways.
The localization of PYK-2 at the site of cell contact dur-
ing conjugate formation could be explained by its associa-
tion with the MTOC, but such phenomenon would also
imply the topological restricted regulation of signaling
events at the site of intercellular contacts such as the
aforementioned vesicle secretion or cell adhesion. In this
regard, it has been shown that PYK-2 is involved in the
outside-in signaling mediated by integrins, which are in-
volved in NK cell adhesion to their targets, and act as co-
stimulatory receptors during NK cell function (Astier et al.,
1997; Gismondi et al., 1997; Ma et al., 1997). In addition, it
is worth mentioning that a small fraction of PYK-2 is lo-
cated at the advancing front of some polarized NK cells,
the site that nucleates cell adhesion. Furthermore, PYK-2
was observed predominantly concentrated in the area of
cell adhesion in polyclonal NK-target cell conjugates. The
translocation of PYK-2 to the site of contact with target
cell upon the triggering of cytotoxic activity suggests that
this enzyme participates in the signaling mediated by inte-
grins during NK cell activation. In agreement with this
possibility, we found that PYK-2 colocalizes with paxillin
at the site of MTOC and that both proteins are translocated
to the cell–cell contact area of NK–target cell–specific con-
jugates during the cytotoxic process. In this regard, it has
been recently reported the constitutive association of PYK-2
with paxillin, which has been largely implicated in the for-
mation of adhesion structures (Burridge et al., 1997; Gis-
mondi et al., 1997).
However, several pieces of evidence indicate that inte-
grin signaling does not seem to account by itself for the ac-
tivation and translocation of PYK-2 observed after the
triggering of cytotoxic activity by sensitive target cells.
First, the interaction of NK cells with FN through b1 inte-
grins does not induce the translocation of PYK-2 and the
MTOC. Second, we found adhesion of NK cells, likely me-
diated by b2 integrins, to both sensitive and resistant tar-
get cells, but the translocation and activation of PYK-2
was only induced by targets that elicited NK cell cytotoxic-
ity. Furthermore, PYK-2 translocation was induced upon
specific recognition of MHC class I molecules by the acti-
vatory NK cell receptor CD94/NKG2C. In addition, we
found that the signaling through the inhibitory receptor
CD94/NKG2A, specifically inhibited both PYK-2 activa-
tion and translocation. Therefore, our data demonstrate
that the translocation and activation of this enzyme is
closely associated with triggering of the cascade of signal-
ing events that induce NK cell cytotoxicity and that, there-
fore, is specifically regulated by MHC receptors. In agree-
ment with this point, it has been reported that engagement
of the T cell receptor triggers PYK-2 activation (Berg and
Ostergaard, 1997; Ganju et al., 1997; Qian et al., 1997).
The compartmentalization of PYK-2 may imply several
important issues concerning the function of PYK-2 in NK
cells. First, the colocalization of PYK-2 with the MTOC
suggests a role for this tyrosine kinase or its associated pro-
teins in phosphorylating different cytoskeletal elements as
well as other effector-associated proteins upon the trigger-
ing of cytotoxic activity. In this regard, different protein
targets for PYK-2 have been recently described, including
a GTPase-activating protein designated Pap. Pap exhibits
a strong GTPase-activating protein activity towards differ-
ent small GTPases of the Arf family, and has been impli-
cated in the control of vesicular trafficking (Andreev et al.,
1999; Lakkakorpi et al., 1999; Lev et al., 1999). Polarized
vesicle secretion has been described to occur during the
killing response of lymphocytes (Kupfer and Singer, 1989).
In an attempt to further assess the involvement of PYK-2
in the cytotoxic activity of NK cells, we used a vaccinia vi-
rus system overexpressing PYK-2 wt and a kinase dead
mutant PYK-2 (K-M). The infection with vaccinia viruses
has been used previously to test the function of individual
receptor molecules in NK cells and the involvement of the
tyrosine phosphatase SHP-1 in KIR-mediated signaling
(Wagtmann et al., 1995; Binstadt et al., 1996). Our results
showing the inhibitory effect of overexpressing either the
wt or a kinase dead PYK-2 in the NK killing response are
unexpected, but are consistent with an additional role of
PYK-2 as a scaffolding protein. This putative role of PYK-2
could not be overcome by the kinase activity of PYK-2
wt. Since proteins such as paxillin, p130Cas, and Graf bind
to PYK-2 in a phosphorylation- and kinase-independent
manner (Gismondi et al., 1997), it is feasible that PYK-2
may indeed function as a linker protein in the intracellular
signal transduction pathways activated by the NK-sensi-
tive target cell interaction, which would be deregulated
upon its overexpression, thus resulting in nonfunctional
signaling complexes. This possible role of PYK-2 as an
adapter molecule, independently of its kinase activity has
also been suggested for FAK to explain the effects of its
overexpression on the motility of CHO cells (Cary et al.,
1996). Our finding on the prevention of the rearrangement
of microtubules and the translocation of MTOC upon the
overexpression of PYK-2 supports this view. However, the
issue of the possible function of the kinase activity of
PYK-2 during cytotoxicity, which may play a role since
PYK-2 becomes activated as a consequence of activatory
signals, remains uncertain. In this regard, a recent report
described that overexpression of wild-type SHP-1 blocks
tyrosine phosphorylation of PYK-2 (Kumar et al., 1999).
This tyrosine phosphatase has been involved in KIR-medi-
ated inhibition of cytotoxicity (Binstadt et al., 1996), and it
would be feasible that this inhibitory effect via SHP-1
phosphatases on cytotoxicity could be mediated by PYK-2
inhibition. In addition, the kinase activity of PYK-2 could
be important for its adapter role, since the association of
important kinases which would be involved in cytotoxicity,
such as Src, is dependent on the autophosphorylation of
the Tyr402 of PYK-2 (Schlaepfer et al., 1999). The precise
mechanism of action of PYK-2 in NK cell cytotoxicity de-
serves further research.
In summary, our data indicate that the specific recogni-
tion of target cell by NK cell receptors directs the translo-
cation and activation of PYK-2, paxillin, and MTOC fromThe Journal of Cell Biology, Volume 149, 2000 1260
the uropod to the cell–cell contact area. In addition, PYK-2
regulates NK cell cytotoxic activity. These findings further
support the important role of cell compartmentalization in
the key functions of immune cells.
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Note Added in Proof. In a recent paper, another group has also shown a
functional role for PYK-2 in NK cell cytotoxicity (Gismondi, A., J. Jaco-
belli, F. Mainiero, R. Paolini, M. Piccoli, L. Frati, and A. Santoni. 2000.
Functional role for proline-rich tyrosine kinase 2 in NK-cell–mediated
natural cytotoxicity. J. Immunol. 164:2272–2276.
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